Image Description (Avet Logo)
Paclitaxel Injection, Solution
Product Images NDC 23155-882
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Paclitaxel (NDC 23155-882). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Paclitaxel-image1 (Paclitaxel Image1)
Chemical structure of paclitaxel, the active ingredient in PACLITAXEL PACLITAXEL injection, solution for intravenous use by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.*
Paclitaxel-image2 (Paclitaxel Image2)
A Kaplan-Meier survival curve graph depicting the proportion surviving over a period of up to 5 years for two groups labeled Cc and Tc. The graph includes a table showing sample sizes (N), number of events, and hazard ratio (HR) with confidence interval (CI) for the comparison between groups. Number at risk data is displayed for each year up to 4 years.*
Paclitaxel-image3 (Paclitaxel Image3)
A Kaplan-Meier survival curve graph showing the proportion surviving over 5 years for two groups labeled Cc and Tc. The graph includes number at risk data at multiple time points and a small inset table summarizing group sizes, number of events, and hazard ratio with 95% confidence interval.*
Paclitaxel-image4 (Paclitaxel Image4)
A line graph showing the proportion of disease-free patients over a four-year period, comparing two groups labeled AC and AC+T. The vertical axis represents the proportion disease-free, and the horizontal axis represents time in years. The chart includes a table with numerical data for number of events, hazard ratios, and confidence intervals for both groups, as well as the number of patients at risk at different time points.*
Paclitaxel-image5 (Paclitaxel Image5)
A survival curve chart comparing the proportion surviving over 4 years for two treatment groups labeled AC and AC+T. The graph includes a table with number of events, hazard ratio (HR), and 95% confidence interval (CI) for these groups, as well as numbers at risk at various time points.*
Paclitaxel-image6 (Paclitaxel Image6)
A survival curve graph displaying the proportion of patients disease free over a 4-year period, comparing two groups labeled AC and AC+T. The vertical axis shows proportion disease free from 0 to 1, and the horizontal axis shows time in years from 0 to 4. The chart includes hazard ratio data and number of events, along with numbers at risk for each group at different time points.*
Paclitaxel-image7 (Paclitaxel Image7)
A Kaplan-Meier survival curve chart comparing the proportion of patients remaining disease-free over a period of 4 years between two treatment groups labeled AC and AC+T. The x-axis represents years, and the y-axis shows the proportion disease-free. The chart includes a small table displaying number of events, hazard ratio (HR), and confidence interval (CI) for each group, along with numbers at risk at various time points.*
Paclitaxel-image8 (Paclitaxel Image8)
A Kaplan-Meier survival curve comparing proportion disease-free over time (years) between two treatment groups labeled AC and AC+T. The graph includes the number at risk at various time points and a hazard ratio with confidence interval from a tabulated inset within the figure.*
Paclitaxel-image9 (Paclitaxel Image9)
A Kaplan-Meier survival curve showing the proportion of patients disease-free over four years comparing two treatments labeled AC and AC+T. The graph includes a risk table and hazard ratio data comparing events in each treatment group.*
100mg (Pacli 100 mg)
The label for Paclitaxel Injection, USP 100 mg/16.7 mL (6 mg/mL) multiple dose vial by Avet Pharmaceuticals features dosage details and cautions. It states each mL contains 6 mg paclitaxel, includes dilution warning, cytotoxic agent notice, storage instructions between 20° to 25°C, and handling precautions like wearing gloves. The label includes NDC 23155-883-31 and manufacturing details with barcode.*
300mg (Pacli 300 mg)
Packaging label for Paclitaxel Injection, USP 300 mg/50 mL (6 mg/mL) sterile multiple dose vial. The label states it is a cytotoxic agent with a caution that dilution is required prior to IV infusion. It is manufactured for Avet Pharmaceuticals Inc. and includes storage instructions and ingredient details.*
30mg (Pacli 30mg)
Packaging label for Paclitaxel Injection, USP 30 mg/5 mL (6 mg/mL) solution for intravenous injection. The label indicates a 1 x 5 mL vial size, manufactured by Avet Pharmaceuticals Inc. It highlights that the drug is a cytotoxic agent, sterile, and a multiple dose vial. Important warnings include a caution for dilution required prior to IV infusion.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
